Literature DB >> 29575047

Assessment of MR-based R2* and quantitative susceptibility mapping for the quantification of liver iron concentration in a mouse model at 7T.

Gregory Simchick1,2, Zhi Liu3, Tamas Nagy4, May Xiong3, Qun Zhao1,2.   

Abstract

PURPOSE: To assess the feasibility of quantifying liver iron concentration (LIC) using R2* and quantitative susceptibility mapping (QSM) at a high field strength of 7 Tesla (T).
METHODS: Five different concentrations of Fe-dextran were injected into 12 mice to produce various degrees of liver iron overload. After mice were sacrificed, blood and liver samples were harvested. Ferritin enzyme-linked immunosorbent assay (ELISA) and inductively coupled plasma mass spectrometry were performed to quantify serum ferritin concentration and LIC. Multiecho gradient echo MRI was conducted to estimate R2* and the magnetic susceptibility of each liver sample through complex nonlinear least squares fitting and a morphology enabled dipole inversion method, respectively.
RESULTS: Average estimates of serum ferritin concentration, LIC, R2*, and susceptibility all show good linear correlations with injected Fe-dextran concentration; however, the standard deviations in the estimates of R2* and susceptibility increase with injected Fe-dextran concentration. Both R2* and susceptibility measurements also show good linear correlations with LIC (R2  = 0.78 and R2  = 0.91, respectively), and a susceptibility-to-LIC conversion factor of 0.829 ppm/(mg/g wet) is derived.
CONCLUSION: The feasibility of quantifying LIC using MR-based  R2* and QSM at a high field strength of 7T is demonstrated. Susceptibility quantification, which is an intrinsic property of tissues and benefits from being field-strength independent, is more robust than R2* quantification in this ex vivo study. A susceptibility-to-LIC conversion factor is presented that agrees relatively well with previously published QSM derived results obtained at 1.5T and 3T.
© 2018 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  zzm321990R2* mapping; liver iron concentration; liver iron overload; mouse model; quantitative susceptibility mapping

Mesh:

Substances:

Year:  2018        PMID: 29575047      PMCID: PMC6107404          DOI: 10.1002/mrm.27173

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  79 in total

1.  Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques.

Authors:  H L Bonkovsky; R B Rubin; E E Cable; A Davidoff; T H Rijcken; D D Stark
Journal:  Radiology       Date:  1999-07       Impact factor: 11.105

Review 2.  An update on iron chelation therapy.

Authors:  Erika Poggiali; Elena Cassinerio; Laura Zanaboni; Maria Domenica Cappellini
Journal:  Blood Transfus       Date:  2012-06-27       Impact factor: 3.443

3.  Magnetic susceptibility as a B0 field strength independent MRI biomarker of liver iron overload.

Authors:  Diego Hernando; Rachel J Cook; Carol Diamond; Scott B Reeder
Journal:  Magn Reson Med       Date:  2013-06-25       Impact factor: 4.668

4.  On the performance of T2* correction methods for quantification of hepatic fat content.

Authors:  Scott B Reeder; Emily K Bice; Huanzhou Yu; Diego Hernando; Angel R Pineda
Journal:  Magn Reson Med       Date:  2011-06-09       Impact factor: 4.668

5.  Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy.

Authors:  P Harmatz; E Butensky; K Quirolo; R Williams; L Ferrell; T Moyer; D Golden; L Neumayr; E Vichinsky
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

6.  The use of appropriate calibration curves corrects for systematic differences in liver R2* values measured using different software packages.

Authors:  Antonella Meloni; Hugh Y Rienhoff; Amber Jones; Alessia Pepe; Massimo Lombardi; John C Wood
Journal:  Br J Haematol       Date:  2013-03-18       Impact factor: 6.998

7.  Magnetic-susceptibility measurement of human iron stores.

Authors:  G M Brittenham; D E Farrell; J W Harris; E S Feldman; E H Danish; W A Muir; J H Tripp; E M Bellon
Journal:  N Engl J Med       Date:  1982-12-30       Impact factor: 91.245

8.  Relationships between MR transverse relaxation parameters R*(2), R(2) and R'(2) and hepatic iron content in thalassemic mice at 1.5 T and 3 T.

Authors:  Ruitian Song; Wei Lin; Qiukan Chen; Toshio Asakura; Felix W Wehrli; Hee Kwon Song
Journal:  NMR Biomed       Date:  2008-07       Impact factor: 4.044

9.  Multivariate modelling with (1)H NMR of pleural effusion in murine cerebral malaria.

Authors:  Soumita Ghosh; Arjun Sengupta; Shobhona Sharma; Haripalsingh M Sonawat
Journal:  Malar J       Date:  2011-11-02       Impact factor: 2.979

10.  Studies of Secondary Melanoma on C57BL/6J Mouse Liver Using 1H NMR Metabolomics.

Authors:  Ju Feng; Nancy G Isern; Sarah D Burton; Jian Zhi Hu
Journal:  Metabolites       Date:  2013-10-31
View more
  4 in total

1.  Sensitivity of quantitative relaxometry and susceptibility mapping to microscopic iron distribution.

Authors:  Timothy J Colgan; Gesine Knobloch; Scott B Reeder; Diego Hernando
Journal:  Magn Reson Med       Date:  2019-08-18       Impact factor: 4.668

2.  Quantitative ferumoxytol-enhanced MRI in pregnancy: A feasibility study in the nonhuman primate.

Authors:  Ante Zhu; Scott B Reeder; Kevin M Johnson; Sydney M Nguyen; Sean B Fain; Ian M Bird; Thaddeus G Golos; Oliver Wieben; Dinesh M Shah; Diego Hernando
Journal:  Magn Reson Imaging       Date:  2019-10-23       Impact factor: 2.546

3.  Fat spectral modeling on triglyceride composition quantification using chemical shift encoded magnetic resonance imaging.

Authors:  Gregory Simchick; Amelia Yin; Hang Yin; Qun Zhao
Journal:  Magn Reson Imaging       Date:  2018-06-19       Impact factor: 2.546

4.  Abdominal magnetic resonance imaging examination of Tibetan patients with abnormal iron metabolism and a preliminary study of correlations with blood cell analysis.

Authors:  Yi Zhou; Jin-Li Meng; Li Feng; Yong-Hong Huang; Jin Ye; Man Li; Zhong-You Xu; Xiang-Wei Li; Fang Yuan; Bin Song
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.